nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—Slurred speech—Cisplatin—esophageal cancer	0.013	0.0422	CcSEcCtD
Triazolam—Dysaesthesia—Capecitabine—esophageal cancer	0.00994	0.0321	CcSEcCtD
Triazolam—Dysarthria—Cisplatin—esophageal cancer	0.00617	0.0199	CcSEcCtD
Triazolam—Hearing impaired—Cisplatin—esophageal cancer	0.00613	0.0198	CcSEcCtD
Triazolam—Pain—Carboplatin—esophageal cancer	0.00607	0.0196	CcSEcCtD
Triazolam—Memory impairment—Capecitabine—esophageal cancer	0.00548	0.0177	CcSEcCtD
Triazolam—Eye irritation—Capecitabine—esophageal cancer	0.00504	0.0163	CcSEcCtD
Triazolam—Deafness—Cisplatin—esophageal cancer	0.00473	0.0153	CcSEcCtD
Triazolam—Dysarthria—Capecitabine—esophageal cancer	0.00455	0.0147	CcSEcCtD
Triazolam—Hearing impaired—Capecitabine—esophageal cancer	0.00452	0.0146	CcSEcCtD
Triazolam—Amnesia—Cisplatin—esophageal cancer	0.00451	0.0146	CcSEcCtD
Triazolam—Coordination abnormal—Capecitabine—esophageal cancer	0.00438	0.0141	CcSEcCtD
Triazolam—Depressed level of consciousness—Capecitabine—esophageal cancer	0.00415	0.0134	CcSEcCtD
Triazolam—Irritability—Cisplatin—esophageal cancer	0.00404	0.0131	CcSEcCtD
Triazolam—Cramp muscle—Cisplatin—esophageal cancer	0.00381	0.0123	CcSEcCtD
Triazolam—Mental disability—Capecitabine—esophageal cancer	0.00373	0.0121	CcSEcCtD
Triazolam—Sleep disorder—Capecitabine—esophageal cancer	0.00361	0.0117	CcSEcCtD
Triazolam—Sweating increased—Cisplatin—esophageal cancer	0.00357	0.0115	CcSEcCtD
Triazolam—Deafness—Capecitabine—esophageal cancer	0.00349	0.0113	CcSEcCtD
Triazolam—Glossitis—Methotrexate—esophageal cancer	0.00347	0.0112	CcSEcCtD
Triazolam—Hepatic failure—Capecitabine—esophageal cancer	0.00347	0.0112	CcSEcCtD
Triazolam—Dysarthria—Methotrexate—esophageal cancer	0.00339	0.0109	CcSEcCtD
Triazolam—Amnesia—Capecitabine—esophageal cancer	0.00332	0.0107	CcSEcCtD
Triazolam—Stomatitis—Cisplatin—esophageal cancer	0.00318	0.0103	CcSEcCtD
Triazolam—Osteoarthritis—Capecitabine—esophageal cancer	0.00312	0.0101	CcSEcCtD
Triazolam—Depressed level of consciousness—Methotrexate—esophageal cancer	0.00309	0.00999	CcSEcCtD
Triazolam—Irritability—Capecitabine—esophageal cancer	0.00298	0.00963	CcSEcCtD
Triazolam—Urinary retention—Capecitabine—esophageal cancer	0.00297	0.00959	CcSEcCtD
Triazolam—Mood swings—Capecitabine—esophageal cancer	0.00296	0.00955	CcSEcCtD
Triazolam—Ataxia—Capecitabine—esophageal cancer	0.00294	0.00948	CcSEcCtD
Triazolam—Visual impairment—Cisplatin—esophageal cancer	0.00282	0.00912	CcSEcCtD
Triazolam—Muscular weakness—Capecitabine—esophageal cancer	0.00275	0.0089	CcSEcCtD
Triazolam—Tinnitus—Cisplatin—esophageal cancer	0.00273	0.00883	CcSEcCtD
Triazolam—Sweating increased—Capecitabine—esophageal cancer	0.00263	0.00849	CcSEcCtD
Triazolam—Hepatic failure—Methotrexate—esophageal cancer	0.00259	0.00835	CcSEcCtD
Triazolam—Erythema—Cisplatin—esophageal cancer	0.00255	0.00824	CcSEcCtD
Triazolam—Dysuria—Capecitabine—esophageal cancer	0.00252	0.00815	CcSEcCtD
Triazolam—Flatulence—Cisplatin—esophageal cancer	0.00251	0.00812	CcSEcCtD
Triazolam—Visual disturbance—Methotrexate—esophageal cancer	0.00245	0.00792	CcSEcCtD
Triazolam—Muscle spasms—Cisplatin—esophageal cancer	0.00245	0.00792	CcSEcCtD
Triazolam—Tremor—Cisplatin—esophageal cancer	0.00239	0.00772	CcSEcCtD
Triazolam—Ill-defined disorder—Cisplatin—esophageal cancer	0.00237	0.00765	CcSEcCtD
Triazolam—Stomatitis—Capecitabine—esophageal cancer	0.00235	0.00758	CcSEcCtD
Triazolam—Jaundice—Capecitabine—esophageal cancer	0.00235	0.00758	CcSEcCtD
Triazolam—Osteoarthritis—Methotrexate—esophageal cancer	0.00232	0.00751	CcSEcCtD
Triazolam—Malaise—Cisplatin—esophageal cancer	0.0023	0.00743	CcSEcCtD
Triazolam—Irritability—Methotrexate—esophageal cancer	0.00222	0.00717	CcSEcCtD
Triazolam—Mood swings—Methotrexate—esophageal cancer	0.0022	0.00711	CcSEcCtD
Triazolam—Ataxia—Methotrexate—esophageal cancer	0.00219	0.00706	CcSEcCtD
Triazolam—Anxiety—Cisplatin—esophageal cancer	0.00216	0.00699	CcSEcCtD
Triazolam—Discomfort—Cisplatin—esophageal cancer	0.00215	0.00693	CcSEcCtD
Triazolam—Oedema—Cisplatin—esophageal cancer	0.00208	0.00672	CcSEcCtD
Triazolam—Visual impairment—Capecitabine—esophageal cancer	0.00208	0.00672	CcSEcCtD
Triazolam—Tachycardia—Cisplatin—esophageal cancer	0.00203	0.00656	CcSEcCtD
Triazolam—Tinnitus—Capecitabine—esophageal cancer	0.00201	0.00651	CcSEcCtD
Triazolam—Hyperhidrosis—Cisplatin—esophageal cancer	0.00201	0.0065	CcSEcCtD
Triazolam—Anorexia—Cisplatin—esophageal cancer	0.00198	0.00641	CcSEcCtD
Triazolam—Flunitrazepam—CYP2A6—esophageal cancer	0.00193	0.261	CrCbGaD
Triazolam—Erythema—Capecitabine—esophageal cancer	0.00188	0.00607	CcSEcCtD
Triazolam—Dysuria—Methotrexate—esophageal cancer	0.00188	0.00607	CcSEcCtD
Triazolam—Paraesthesia—Cisplatin—esophageal cancer	0.00187	0.00604	CcSEcCtD
Triazolam—Dyspnoea—Cisplatin—esophageal cancer	0.00186	0.006	CcSEcCtD
Triazolam—Flatulence—Capecitabine—esophageal cancer	0.00185	0.00599	CcSEcCtD
Triazolam—Dysgeusia—Capecitabine—esophageal cancer	0.00184	0.00595	CcSEcCtD
Triazolam—Decreased appetite—Cisplatin—esophageal cancer	0.00181	0.00585	CcSEcCtD
Triazolam—Muscle spasms—Capecitabine—esophageal cancer	0.00181	0.00584	CcSEcCtD
Triazolam—Drowsiness—Methotrexate—esophageal cancer	0.00179	0.00579	CcSEcCtD
Triazolam—Pain—Cisplatin—esophageal cancer	0.00178	0.00575	CcSEcCtD
Triazolam—Tremor—Capecitabine—esophageal cancer	0.00176	0.00569	CcSEcCtD
Triazolam—Stomatitis—Methotrexate—esophageal cancer	0.00175	0.00564	CcSEcCtD
Triazolam—Ill-defined disorder—Capecitabine—esophageal cancer	0.00174	0.00564	CcSEcCtD
Triazolam—Feeling abnormal—Cisplatin—esophageal cancer	0.00172	0.00554	CcSEcCtD
Triazolam—Malaise—Capecitabine—esophageal cancer	0.0017	0.00548	CcSEcCtD
Triazolam—Syncope—Capecitabine—esophageal cancer	0.00169	0.00545	CcSEcCtD
Triazolam—Palpitations—Capecitabine—esophageal cancer	0.00166	0.00537	CcSEcCtD
Triazolam—Loss of consciousness—Capecitabine—esophageal cancer	0.00165	0.00534	CcSEcCtD
Triazolam—Hypertension—Capecitabine—esophageal cancer	0.00162	0.00524	CcSEcCtD
Triazolam—Chest pain—Capecitabine—esophageal cancer	0.0016	0.00517	CcSEcCtD
Triazolam—Anxiety—Capecitabine—esophageal cancer	0.0016	0.00515	CcSEcCtD
Triazolam—Discomfort—Capecitabine—esophageal cancer	0.00158	0.00511	CcSEcCtD
Triazolam—Dry mouth—Capecitabine—esophageal cancer	0.00157	0.00506	CcSEcCtD
Triazolam—Visual impairment—Methotrexate—esophageal cancer	0.00155	0.00501	CcSEcCtD
Triazolam—Flurazepam—CYP2A6—esophageal cancer	0.00155	0.21	CrCbGaD
Triazolam—Confusional state—Capecitabine—esophageal cancer	0.00155	0.005	CcSEcCtD
Triazolam—Oedema—Capecitabine—esophageal cancer	0.00153	0.00496	CcSEcCtD
Triazolam—Hypersensitivity—Cisplatin—esophageal cancer	0.00153	0.00495	CcSEcCtD
Triazolam—Shock—Capecitabine—esophageal cancer	0.00151	0.00488	CcSEcCtD
Triazolam—Tinnitus—Methotrexate—esophageal cancer	0.0015	0.00484	CcSEcCtD
Triazolam—Tachycardia—Capecitabine—esophageal cancer	0.0015	0.00484	CcSEcCtD
Triazolam—Asthenia—Cisplatin—esophageal cancer	0.00149	0.00482	CcSEcCtD
Triazolam—Hyperhidrosis—Capecitabine—esophageal cancer	0.00148	0.00479	CcSEcCtD
Triazolam—Anorexia—Capecitabine—esophageal cancer	0.00146	0.00473	CcSEcCtD
Triazolam—Diarrhoea—Cisplatin—esophageal cancer	0.00142	0.0046	CcSEcCtD
Triazolam—Erythema—Methotrexate—esophageal cancer	0.0014	0.00452	CcSEcCtD
Triazolam—Insomnia—Capecitabine—esophageal cancer	0.00139	0.00448	CcSEcCtD
Triazolam—Paraesthesia—Capecitabine—esophageal cancer	0.00138	0.00445	CcSEcCtD
Triazolam—Dysgeusia—Methotrexate—esophageal cancer	0.00137	0.00443	CcSEcCtD
Triazolam—Dyspnoea—Capecitabine—esophageal cancer	0.00137	0.00442	CcSEcCtD
Triazolam—Decreased appetite—Capecitabine—esophageal cancer	0.00133	0.00431	CcSEcCtD
Triazolam—Vomiting—Cisplatin—esophageal cancer	0.00132	0.00428	CcSEcCtD
Triazolam—Fatigue—Capecitabine—esophageal cancer	0.00132	0.00427	CcSEcCtD
Triazolam—Constipation—Capecitabine—esophageal cancer	0.00131	0.00424	CcSEcCtD
Triazolam—Pain—Capecitabine—esophageal cancer	0.00131	0.00424	CcSEcCtD
Triazolam—Dermatitis—Cisplatin—esophageal cancer	0.00131	0.00424	CcSEcCtD
Triazolam—Ill-defined disorder—Methotrexate—esophageal cancer	0.0013	0.0042	CcSEcCtD
Triazolam—Feeling abnormal—Capecitabine—esophageal cancer	0.00126	0.00409	CcSEcCtD
Triazolam—Malaise—Methotrexate—esophageal cancer	0.00126	0.00408	CcSEcCtD
Triazolam—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00125	0.00405	CcSEcCtD
Triazolam—Nausea—Cisplatin—esophageal cancer	0.00124	0.00399	CcSEcCtD
Triazolam—Abdominal pain—Capecitabine—esophageal cancer	0.00121	0.00392	CcSEcCtD
Triazolam—Chest pain—Methotrexate—esophageal cancer	0.00119	0.00385	CcSEcCtD
Triazolam—Discomfort—Methotrexate—esophageal cancer	0.00118	0.0038	CcSEcCtD
Triazolam—Confusional state—Methotrexate—esophageal cancer	0.00115	0.00372	CcSEcCtD
Triazolam—Hypersensitivity—Capecitabine—esophageal cancer	0.00113	0.00365	CcSEcCtD
Triazolam—Hyperhidrosis—Methotrexate—esophageal cancer	0.0011	0.00357	CcSEcCtD
Triazolam—Asthenia—Capecitabine—esophageal cancer	0.0011	0.00356	CcSEcCtD
Triazolam—Anorexia—Methotrexate—esophageal cancer	0.00109	0.00352	CcSEcCtD
Triazolam—Pruritus—Capecitabine—esophageal cancer	0.00109	0.00351	CcSEcCtD
Triazolam—Diarrhoea—Capecitabine—esophageal cancer	0.00105	0.00339	CcSEcCtD
Triazolam—Insomnia—Methotrexate—esophageal cancer	0.00103	0.00334	CcSEcCtD
Triazolam—Paraesthesia—Methotrexate—esophageal cancer	0.00103	0.00331	CcSEcCtD
Triazolam—Dyspnoea—Methotrexate—esophageal cancer	0.00102	0.00329	CcSEcCtD
Triazolam—Somnolence—Methotrexate—esophageal cancer	0.00102	0.00328	CcSEcCtD
Triazolam—Dizziness—Capecitabine—esophageal cancer	0.00101	0.00328	CcSEcCtD
Triazolam—Decreased appetite—Methotrexate—esophageal cancer	0.000993	0.00321	CcSEcCtD
Triazolam—Fatigue—Methotrexate—esophageal cancer	0.000985	0.00318	CcSEcCtD
Triazolam—Pain—Methotrexate—esophageal cancer	0.000977	0.00316	CcSEcCtD
Triazolam—Vomiting—Capecitabine—esophageal cancer	0.000976	0.00315	CcSEcCtD
Triazolam—Dermatitis—Capecitabine—esophageal cancer	0.000967	0.00312	CcSEcCtD
Triazolam—Headache—Capecitabine—esophageal cancer	0.000961	0.00311	CcSEcCtD
Triazolam—Diazepam—PTGS1—esophageal cancer	0.000942	0.128	CrCbGaD
Triazolam—Feeling abnormal—Methotrexate—esophageal cancer	0.000941	0.00304	CcSEcCtD
Triazolam—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000934	0.00302	CcSEcCtD
Triazolam—Nausea—Capecitabine—esophageal cancer	0.000911	0.00294	CcSEcCtD
Triazolam—Abdominal pain—Methotrexate—esophageal cancer	0.000903	0.00292	CcSEcCtD
Triazolam—Hypersensitivity—Methotrexate—esophageal cancer	0.000842	0.00272	CcSEcCtD
Triazolam—Asthenia—Methotrexate—esophageal cancer	0.00082	0.00265	CcSEcCtD
Triazolam—Pruritus—Methotrexate—esophageal cancer	0.000808	0.00261	CcSEcCtD
Triazolam—Clobazam—ABCB1—esophageal cancer	0.000784	0.106	CrCbGaD
Triazolam—Diarrhoea—Methotrexate—esophageal cancer	0.000782	0.00252	CcSEcCtD
Triazolam—Dizziness—Methotrexate—esophageal cancer	0.000755	0.00244	CcSEcCtD
Triazolam—Vomiting—Methotrexate—esophageal cancer	0.000726	0.00235	CcSEcCtD
Triazolam—Dermatitis—Methotrexate—esophageal cancer	0.00072	0.00232	CcSEcCtD
Triazolam—Headache—Methotrexate—esophageal cancer	0.000716	0.00231	CcSEcCtD
Triazolam—Nausea—Methotrexate—esophageal cancer	0.000679	0.00219	CcSEcCtD
Triazolam—Chlorprothixene—ABCB1—esophageal cancer	0.000617	0.0836	CrCbGaD
Triazolam—Flurazepam—ABCB1—esophageal cancer	0.000576	0.078	CrCbGaD
Triazolam—Midazolam—ABCB1—esophageal cancer	0.000534	0.0723	CrCbGaD
Triazolam—Diazepam—ABCB1—esophageal cancer	0.000458	0.062	CrCbGaD
Triazolam—CYP2C8—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000433	0.000634	CbGpPWpGaD
Triazolam—CYP2C9—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000433	0.000634	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000432	0.000633	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000431	0.000631	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000431	0.000631	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000424	0.00062	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—PTGS1—esophageal cancer	0.00042	0.000615	CbGpPWpGaD
Triazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000417	0.000611	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000414	0.000606	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000414	0.000606	CbGpPWpGaD
Triazolam—CYP2C8—Biological oxidations—CYP19A1—esophageal cancer	0.000413	0.000604	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.00041	0.000601	CbGpPWpGaD
Triazolam—CYP2C8—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000407	0.000596	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000405	0.000592	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000392	0.000574	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000381	0.000558	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000376	0.000551	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—CYP1B1—esophageal cancer	0.000357	0.000523	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000355	0.00052	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—BLVRB—esophageal cancer	0.000354	0.000519	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—SLC52A3—esophageal cancer	0.000354	0.000519	CbGpPWpGaD
Triazolam—CYP2C9—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000352	0.000516	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.00035	0.000512	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000345	0.000505	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000341	0.000499	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—CYP19A1—esophageal cancer	0.000336	0.000492	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000336	0.000491	CbGpPWpGaD
Triazolam—CYP2C9—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000331	0.000485	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000331	0.000484	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000327	0.000478	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000318	0.000465	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000314	0.000459	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000311	0.000455	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000309	0.000453	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CA1—esophageal cancer	0.000301	0.000441	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—SLC10A2—esophageal cancer	0.000301	0.000441	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000299	0.000438	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000296	0.000433	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000292	0.000428	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.00029	0.000425	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.00029	0.000424	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000287	0.00042	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000286	0.000419	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000285	0.000417	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.00028	0.00041	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000279	0.000408	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000278	0.000408	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000277	0.000406	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000277	0.000405	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000277	0.000405	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CA2—esophageal cancer	0.000276	0.000403	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000274	0.000401	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000273	0.0004	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000269	0.000394	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000267	0.000391	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000262	0.000384	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ADH7—esophageal cancer	0.000256	0.000375	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PLCE1—esophageal cancer	0.000256	0.000375	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—BLVRB—esophageal cancer	0.000256	0.000375	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—SLC52A3—esophageal cancer	0.000256	0.000375	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.00025	0.000365	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000239	0.00035	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000236	0.000345	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000233	0.000341	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000232	0.00034	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000229	0.000336	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000228	0.000333	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ADH1B—esophageal cancer	0.000225	0.000329	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000224	0.000328	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—BLVRB—esophageal cancer	0.000222	0.000325	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SLC52A3—esophageal cancer	0.000222	0.000325	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000222	0.000324	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000219	0.00032	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CA1—esophageal cancer	0.000218	0.000319	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—SLC10A2—esophageal cancer	0.000218	0.000319	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—TYMP—esophageal cancer	0.000215	0.000314	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000212	0.000311	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.00021	0.000307	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CYP26A1—esophageal cancer	0.000209	0.000306	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ALOX15—esophageal cancer	0.000203	0.000298	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000203	0.000297	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CA2—esophageal cancer	0.000199	0.000292	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000198	0.00029	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTO1—esophageal cancer	0.000194	0.000284	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—TPI1—esophageal cancer	0.000194	0.000284	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000192	0.000281	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CA1—esophageal cancer	0.000189	0.000276	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SLC10A2—esophageal cancer	0.000189	0.000276	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000186	0.000273	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ALDOB—esophageal cancer	0.000186	0.000272	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ADH7—esophageal cancer	0.000185	0.000271	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PLCE1—esophageal cancer	0.000185	0.000271	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000183	0.000268	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—BLVRB—esophageal cancer	0.000181	0.000264	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SLC52A3—esophageal cancer	0.000181	0.000264	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.00018	0.000263	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GAPDH—esophageal cancer	0.000179	0.000262	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000179	0.000261	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CRABP1—esophageal cancer	0.000178	0.00026	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000175	0.000257	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CA2—esophageal cancer	0.000173	0.000253	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GNG7—esophageal cancer	0.000169	0.000247	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000169	0.000247	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ADH1B—esophageal cancer	0.000162	0.000238	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000161	0.000236	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PLCE1—esophageal cancer	0.00016	0.000235	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ADH7—esophageal cancer	0.00016	0.000235	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000159	0.000232	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ALDH2—esophageal cancer	0.000158	0.000232	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—TYMP—esophageal cancer	0.000155	0.000227	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SLC10A2—esophageal cancer	0.000154	0.000225	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CA1—esophageal cancer	0.000154	0.000225	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000153	0.000224	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP26A1—esophageal cancer	0.000151	0.000221	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTT1—esophageal cancer	0.000151	0.00022	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CYP2A6—esophageal cancer	0.000149	0.000218	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ALOX15—esophageal cancer	0.000147	0.000215	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ENO1—esophageal cancer	0.000141	0.000206	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PTGS1—esophageal cancer	0.000141	0.000206	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ADH1B—esophageal cancer	0.000141	0.000206	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CA2—esophageal cancer	0.00014	0.000206	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTO1—esophageal cancer	0.00014	0.000205	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—TPI1—esophageal cancer	0.00014	0.000205	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PSME1—esophageal cancer	0.000139	0.000203	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PSME2—esophageal cancer	0.000139	0.000203	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000137	0.000201	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ALDOB—esophageal cancer	0.000135	0.000197	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—TYMP—esophageal cancer	0.000134	0.000197	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP26A1—esophageal cancer	0.000131	0.000191	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PLCE1—esophageal cancer	0.000131	0.000191	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ADH7—esophageal cancer	0.000131	0.000191	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GAPDH—esophageal cancer	0.00013	0.00019	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000129	0.000189	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CRABP1—esophageal cancer	0.000128	0.000188	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ALOX15—esophageal cancer	0.000127	0.000187	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GNG7—esophageal cancer	0.000122	0.000179	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—TPI1—esophageal cancer	0.000122	0.000178	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTO1—esophageal cancer	0.000122	0.000178	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CYP1B1—esophageal cancer	0.00012	0.000176	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000119	0.000174	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000119	0.000174	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ALDOB—esophageal cancer	0.000117	0.000171	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ADH1B—esophageal cancer	0.000114	0.000168	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ALDH2—esophageal cancer	0.000114	0.000167	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CYP19A1—esophageal cancer	0.000113	0.000165	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GAPDH—esophageal cancer	0.000112	0.000164	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CRABP1—esophageal cancer	0.000111	0.000163	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—TYMP—esophageal cancer	0.000109	0.00016	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTT1—esophageal cancer	0.000109	0.000159	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP2A6—esophageal cancer	0.000108	0.000157	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP26A1—esophageal cancer	0.000106	0.000156	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GNG7—esophageal cancer	0.000106	0.000155	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALOX15—esophageal cancer	0.000104	0.000152	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—HMOX1—esophageal cancer	0.000103	0.000151	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PTGS1—esophageal cancer	0.000102	0.000149	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ENO1—esophageal cancer	0.000102	0.000149	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CA1—esophageal cancer	0.000101	0.000148	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000101	0.000148	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PSME1—esophageal cancer	0.0001	0.000147	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PSME2—esophageal cancer	0.0001	0.000147	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ALDH2—esophageal cancer	9.91e-05	0.000145	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—TPI1—esophageal cancer	9.89e-05	0.000145	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTO1—esophageal cancer	9.89e-05	0.000145	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ABCB1—esophageal cancer	9.88e-05	0.000145	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALDOB—esophageal cancer	9.48e-05	0.000139	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTT1—esophageal cancer	9.42e-05	0.000138	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP2A6—esophageal cancer	9.32e-05	0.000136	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	9.28e-05	0.000136	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CA2—esophageal cancer	9.26e-05	0.000136	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GAPDH—esophageal cancer	9.13e-05	0.000134	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CRABP1—esophageal cancer	9.05e-05	0.000132	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ENO1—esophageal cancer	8.83e-05	0.000129	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PTGS1—esophageal cancer	8.83e-05	0.000129	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PSME2—esophageal cancer	8.7e-05	0.000127	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PSME1—esophageal cancer	8.7e-05	0.000127	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP1B1—esophageal cancer	8.67e-05	0.000127	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PLCE1—esophageal cancer	8.61e-05	0.000126	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ADH7—esophageal cancer	8.61e-05	0.000126	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GNG7—esophageal cancer	8.61e-05	0.000126	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP19A1—esophageal cancer	8.15e-05	0.000119	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALDH2—esophageal cancer	8.06e-05	0.000118	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTT1—esophageal cancer	7.67e-05	0.000112	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.6e-05	0.000111	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP2A6—esophageal cancer	7.58e-05	0.000111	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7.55e-05	0.000111	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ADH1B—esophageal cancer	7.55e-05	0.000111	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP1B1—esophageal cancer	7.51e-05	0.00011	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—HMOX1—esophageal cancer	7.44e-05	0.000109	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—TYMP—esophageal cancer	7.21e-05	0.000106	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ENO1—esophageal cancer	7.19e-05	0.000105	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PTGS1—esophageal cancer	7.19e-05	0.000105	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ABCB1—esophageal cancer	7.14e-05	0.000105	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PSME2—esophageal cancer	7.08e-05	0.000104	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PSME1—esophageal cancer	7.08e-05	0.000104	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP19A1—esophageal cancer	7.06e-05	0.000103	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP26A1—esophageal cancer	7.02e-05	0.000103	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALOX15—esophageal cancer	6.84e-05	0.0001	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CREBBP—esophageal cancer	6.6e-05	9.66e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—TPI1—esophageal cancer	6.52e-05	9.55e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTO1—esophageal cancer	6.52e-05	9.55e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—HMOX1—esophageal cancer	6.44e-05	9.43e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.32e-05	9.25e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALDOB—esophageal cancer	6.25e-05	9.16e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.18e-05	9.05e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ABCB1—esophageal cancer	6.18e-05	9.05e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP1B1—esophageal cancer	6.11e-05	8.95e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GAPDH—esophageal cancer	6.02e-05	8.81e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CRABP1—esophageal cancer	5.97e-05	8.74e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—NOS3—esophageal cancer	5.91e-05	8.65e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP19A1—esophageal cancer	5.75e-05	8.41e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GNG7—esophageal cancer	5.68e-05	8.31e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PTGS2—esophageal cancer	5.41e-05	7.91e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALDH2—esophageal cancer	5.32e-05	7.79e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HMOX1—esophageal cancer	5.24e-05	7.68e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.14e-05	7.53e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTT1—esophageal cancer	5.06e-05	7.41e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ABCB1—esophageal cancer	5.03e-05	7.37e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP2A6—esophageal cancer	5e-05	7.32e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CREBBP—esophageal cancer	4.77e-05	6.99e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ENO1—esophageal cancer	4.74e-05	6.94e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.74e-05	6.94e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.68e-05	6.84e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PSME1—esophageal cancer	4.67e-05	6.84e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PSME2—esophageal cancer	4.67e-05	6.84e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—EP300—esophageal cancer	4.5e-05	6.58e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NOS3—esophageal cancer	4.27e-05	6.25e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CREBBP—esophageal cancer	4.13e-05	6.05e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP1B1—esophageal cancer	4.03e-05	5.9e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PTGS2—esophageal cancer	3.91e-05	5.72e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.81e-05	5.57e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.79e-05	5.55e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NOS3—esophageal cancer	3.7e-05	5.42e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.46e-05	5.06e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PTGS2—esophageal cancer	3.38e-05	4.95e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CREBBP—esophageal cancer	3.36e-05	4.92e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CA—esophageal cancer	3.33e-05	4.87e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.32e-05	4.86e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—EP300—esophageal cancer	3.25e-05	4.76e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NOS3—esophageal cancer	3.01e-05	4.41e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—EP300—esophageal cancer	2.81e-05	4.12e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PTGS2—esophageal cancer	2.75e-05	4.03e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CA—esophageal cancer	2.4e-05	3.52e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—EP300—esophageal cancer	2.29e-05	3.35e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.22e-05	3.25e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CA—esophageal cancer	2.08e-05	3.05e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NOS3—esophageal cancer	1.99e-05	2.91e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.82e-05	2.66e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CA—esophageal cancer	1.69e-05	2.48e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—EP300—esophageal cancer	1.51e-05	2.21e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.12e-05	1.64e-05	CbGpPWpGaD
